BACH-DUONG DINH: Open Payments
NPI 1114327087 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,336 in 77 payments from 15 companies in 2025. Trend: 2023 $1,079 · 2024 $1,225 · 2025 $2,336
Food & beverage: $2,237Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $510 |
| Incyte Corporation | 12 | $335 |
| LEO Pharma Inc. | 6 | $324 |
| GENZYME CORPORATION | 9 | $298 |
| Arcutis Biotherapeutics, Inc. | 7 | $226 |
| Janssen Biotech, Inc. | 7 | $219 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $83 |
| Galderma Laboratories, L.P. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $55 |
Products named: SKYRIZI, OPZELURA, DUPIXENT, ANZUPGO, TREMFYA, Winlevi, Zoryve, RINVOQ.
Industry payments across VA — which companies pay providers there.
